Original Article
Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:340-354
.
(01 June 2022)
This study provided new evidence in pediatric living donor liver allocation. Donor liver with mild portal inflammation would better not be allocated to recipients with high pediatric-end-stage-liver-disease score.
Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:355-362
.
(01 June 2022)
This study revealed the real-world condition of peripancreatic vascular involvement (PVI) in patients with type 1 autoimmune pancreatitis (AIP) and described independent predictors of PVI development in AIP patients. The follow-up showed majority of PVI lesions achieved an improvement after corticosteroid treatment.
Have we really understood when the efforts of laparoscopic liver resection are justified?—a complexity-based appraisal of the differential benefit
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:363-374
.
(01 June 2022)
The favorable biological scenario associated with laparoscopy allows to obtain significant benefits in the setting of complex procedures, constituting the prerequisite for adequate surgical outcome. The effort should be to maximize the laparoscopic approach in high complexity procedures by implementing surgical technique and perioperative management.
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:375-385
.
(01 June 2022)
We validate postoperative liver failure (PHLFS) and mortality risk scores (POMRS) after liver resection for perihilar cholangiocarcinoma, which was established by Western cohort, by Eastern cohort. This external validation study showed that for PHLFS the threshold for discrimination, but the POMRS were not applicable.
Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a multicenter propensity score matching analysis
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:386-399
.
(01 June 2022)
Our study indicated pathological responses (PR) ≥90% was an independent protective factor of incidences of MVI and prognosis; while PR<60% was an independent risk factor of incidences of MVI and prognosis. Patients with PR <60% were more likely to develop multiple recurrences.
Review Article
Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:400-411
.
(01 June 2022)
We propose 3 possible extrahepatic organs that participate in the NAFLD development process in LT patients. Potential mechanisms of NAFLD in LT context and current limitations in preclinical and clinical scenarios are discussed with suggestions for future study.
Editorial from the ACHBPT
Patient with unresectable colorectal liver metastases and asymptomatic primary tumor: end of the debate!
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:412-414
.
(01 June 2022)
Editorial
Neutrophil extracellular traps contribute to the development of hepatocellular carcinoma in NASH by promoting Treg differentiation
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:415-418
.
(01 June 2022)
The role of diet in the management of MAFLD—why does a new disease require a novel, individualized approach?
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:419-421
.
(01 June 2022)
Editorial on “Perihilar Cholangiocarcinoma—Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers”
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:422-424
.
(01 June 2022)
Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:425-429
.
(01 June 2022)
Could “Eating Behavior” be a novel lifestyle factor that modulates risk of gastrointestinal cancers?
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:430-432
.
(01 June 2022)
Pan-peroxisome proliferator-activated receptor agonist lanifibranor as a dominant candidate pharmacological therapy for nonalcoholic fatty liver disease
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:433-435
.
(01 June 2022)
Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:436-438
.
(01 June 2022)
NAFLD or MAFLD: the data behind the debate
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:439-442
.
(01 June 2022)
Identification and treatment of biliary complications after liver transplantation: more relevant than ever
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:443-445
.
(01 June 2022)
Utility of liver resection for breast cancer liver metastases, time for action
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:446-448
.
(01 June 2022)
Genomic alterations in hepatocellular carcinoma and their clinical application to genomic medicine
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:449-452
.
(01 June 2022)
Editorial comment: a review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:453-456
.
(01 June 2022)
Developments in diagnosis and management of post-liver transplantation biliary complications: the radiologist’s perspective
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:457-461
.
(01 June 2022)
Developing a new nomogram to predict early allograft dysfunction after liver transplantation: a nudge in the right direction
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:462-466
.
(01 June 2022)
Editorial on “Uncommon indications for associating liver partition and portal vein ligation for staged hepatectomy: a systematic review”
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:467-469
.
(01 June 2022)
Editorial on “Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?”
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:470-472
.
(01 June 2022)
The challenge of hepatic vein reconstruction in surgical oncology
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:473-476
.
(01 June 2022)
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:477-480
.
(01 June 2022)
Commentary
Is it necessary to target lipid metabolism in different organs for effective treatment of NASH?—the results of the Pan-PPAR Lanifibranor trial
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:481-484
.
(01 June 2022)
Hepatocellular carcinoma as the Rose of Jericho: from the desert of sorafenib, to the blossoming of immunotherapy
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:485-488
.
(01 June 2022)
Robotic pancreaticoduodenectomy after the learning curve—a new hope
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:489-491
.
(01 June 2022)
Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:492-494
.
(01 June 2022)
Letter to the Editor
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:495-497
.
(01 June 2022)
Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen
HepatoBiliary Surgery and Nutrition
2022;
11
(3)
:498-501
.
(01 June 2022)
